[Elsevier] [Supplementary]Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline每trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial |
|
This post will be closed automatically in 2026-09-27 22:12
Reward10points
|
10
Quantiles via moments
10
Learning to manage vasoactive drugs〞A qualitative interview study with critical care nurses
10
Early high-dose vasopressors in refractory septic shock: A cohort study
10
Quantiles via moments
10
Facile synthesis of boron and nitrogen doped TiO2 as effective catalysts for photocatalytic degradation of emerging micro-pollutants
